Home › Bayer, Dimension Therapeutics partner to develop new gene therapy for hemophilia A
 

Keywords :   


Bayer, Dimension Therapeutics partner to develop new gene therapy for hemophilia A

2014-06-23 15:03:42| Chemicals - Topix.net

Dimension Therapeutics, a company focused on developing novel adeno-associated virus gene therapy treatments for rare diseases, today announced it has entered into a collaboration with Bayer HealthCare for the development and commercialization of a novel gene therapy for the treatment of hemophilia A .

Tags: partner develop therapy gene

Category:Chemicals

Latest from this category

All news
12.11Benjamin Moore Expands Partnership with Roadie to Accelerate Paint Delivery for DIYers and Pros
11.11Clariant Launches Melamine-free Flame Retardant for Intumescent Coatings
11.11Protech Group Acquires Caldwell Chemical Coatings
11.11Asian Paints Reports 2Q 2024-25 Fiscal Results
10.11Clariant Launches Melamine-free Flame Retardant for Intumescent Coatings
Chemicals »
23.11
23.11 85
23.11DANCEWITHDRAGON2 811
23.11 N5000VSE
23.11EZY POWER EDIT6
23.11RR4
23.1126.5 HG
23.11VISSLA
More »